Default
Allergy and immunology
Anaesthesia
Basic research
Cardiovascular medicine
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Dermatology
Emergency medicine
Endocrinology
Epidemiology
Ethics
Evidence-based medicine
Gastroenterology
Genetics
Geriatric medicine / aging
Haematology / blood transfusion
Health economics
Health policy
History of medicine
Infectious diseases
Internal medicine
Laboratory medicine
Legal and forensic medicine
Medical education
Medical informatics
Neurology
Nursing
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Oncology
Ophthalmology
Organisation of health care
Otolaryngology / head and neck surgery
Paediatrics
Palliative care
Pathology
Patient-physician relationship
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Psychosomatics
Public health
Quality of care
Radiology
Rehabilitation medicine
Renal medicine
Respiratory medicine
Rheumatology
Sexual medicine
Sports medicine
Statistics and research methods
Surgery
Transplantation
Travel medicine
Urology
Towards novel reimbursement models for expensive advanced therapy medicinal products (ATMPs)
This article analyses the current legal framework in Switzerland and critically evaluates existing reimbursement models, particularly with respect to their adaptation for advanced therapy medicinal products. As a promising reimbursement arrangement, this paper proposes a model combining outcome-based instalment payments with aspects of the pay for performance and the annuity payment model.
Optimal allocation of limited test resources for the quantification of COVID-19 infections
The proposed methodology can lead to vastly less uncertain predictions for the spread of the disease, thus improving estimates of the effective reproduction number and the future number of unreported infections. This information can provide timely and systematic guidance for the effective identification of infectious individuals and for decision-making regarding lockdown measures and the distribution of vaccines.
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit
People who use drugs are badly affected by chronic hepatitis C. As a result of the pragmatic national drug policy in Switzerland, the majority of persons with an opioid dependency are on opioid agonist therapy (OAT) and therefore in the healthcare system. For years, national guidelines have recommended that all OAT patients be regularly tested for hepatitis C and, if tested positive, referred for treatment.
Response of a European surgical department to the COVID-19 crisis
At first sight, surgery appears to be only peripherally affected by the COVID.19 pandemic. However, the surgical department plays a key role in the response to this crisis. This article aims to provide a blueprint for a general surgery department’s response to this current pandemic crisis and also future events of similar magnitude.
COVID-19 and Iran: swimming with hands tied!
Like many other countries around the world, Iran is contending with the COVID-19 epidemic, but with the additional burden of international sanctions on supplies of medicines and medical equipment.
Diagnostic diversity – an indicator of institutional and regional healthcare quality
The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.
Dual use in the 21st century: emerging risks and global governance
Dual use risks in the second decade of the 21st century are characterised by: diversification of dual use domains, digitalisation of potential threats, and the proliferation of actors.
A buyers’ club to improve access to hepatitis C treatment for vulnerable populations
High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.
Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department
Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.
The inconsistent ethical oversight of healthcare quality data in Switzerland
Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.
